1) Immune-mediated necrotizing myopathy (IMNM)
2) Dermatomyositis, and
3) Inclusion body myositis (IBM)
Yeah. All 3. The worst part is that the IMNM may be triggered by taking a Statin for cholesterol. If anyone had caught this in my muscle biopsy I could have taken a different medicine
But no 👇🏼
2) Dermatomyositis, and
3) Inclusion body myositis (IBM)
Yeah. All 3. The worst part is that the IMNM may be triggered by taking a Statin for cholesterol. If anyone had caught this in my muscle biopsy I could have taken a different medicine
But no 👇🏼
July 24, 2026 at 5:46 PM
1) Immune-mediated necrotizing myopathy (IMNM)
2) Dermatomyositis, and
3) Inclusion body myositis (IBM)
Yeah. All 3. The worst part is that the IMNM may be triggered by taking a Statin for cholesterol. If anyone had caught this in my muscle biopsy I could have taken a different medicine
But no 👇🏼
2) Dermatomyositis, and
3) Inclusion body myositis (IBM)
Yeah. All 3. The worst part is that the IMNM may be triggered by taking a Statin for cholesterol. If anyone had caught this in my muscle biopsy I could have taken a different medicine
But no 👇🏼
📉 Insider Cluster Sell
5 insiders at Immunome Inc. ($IMNM) sold $5.9M in shares over 7 days.
https://earningsfeed.com/companies/1472012-imnm-immunome-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
5 insiders at Immunome Inc. ($IMNM) sold $5.9M in shares over 7 days.
https://earningsfeed.com/companies/1472012-imnm-immunome-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
September 30, 2026 at 4:25 PM
📉 Insider Cluster Sell
5 insiders at Immunome Inc. ($IMNM) sold $5.9M in shares over 7 days.
https://earningsfeed.com/companies/1472012-imnm-immunome-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
5 insiders at Immunome Inc. ($IMNM) sold $5.9M in shares over 7 days.
https://earningsfeed.com/companies/1472012-imnm-immunome-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
imnm limke eat grass mmm
Got a question for ya'll,
What fantasy does your fursona help you live out?
Is your sona strong because you dont see yourself as strong?
is your sona an Ideal you wish you could embody?
My sona has dominion over time because its the one thing I really wish I could control, for example.
What fantasy does your fursona help you live out?
Is your sona strong because you dont see yourself as strong?
is your sona an Ideal you wish you could embody?
My sona has dominion over time because its the one thing I really wish I could control, for example.
June 11, 2026 at 5:06 PM
imnm limke eat grass mmm
Lower Manhattan to the west Village dressed in black riding imnm freezing rain.
Top 10 most dangerous ride ever
Top 10 most dangerous ride ever
December 14, 2025 at 4:01 AM
Lower Manhattan to the west Village dressed in black riding imnm freezing rain.
Top 10 most dangerous ride ever
Top 10 most dangerous ride ever
I got so horny thinking abt @1x1.adder.industries I gorgot how language works imnm
August 29, 2026 at 4:30 PM
I got so horny thinking abt @1x1.adder.industries I gorgot how language works imnm
Another successful day at #ECIM2025 in Florence, Italy ! #posterdiscussion #IMNM #myositis #internalmedicine ☀️
Romain Batton on LinkedIn: #ecim2025 #imnm #internalmedicine #myositis
This week I have the pleasure and great opportunity to attend to the European Congress of Internal Medicine (#ECIM2025) in Florence, Italy 🇮🇹 . It is…
www.linkedin.com
March 6, 2025 at 5:56 PM
Another successful day at #ECIM2025 in Florence, Italy ! #posterdiscussion #IMNM #myositis #internalmedicine ☀️
On #BiotechHangout, Mike Yee, Bruce Booth, Eric Schmidt & Yaron Werber discuss Jefferies Conference, Atlas Year in Review, investor sentiment, #ACR24 recap $AMGN Ph3 & cell therapy data for SLE, SSC, IMNM & lipid ROs: $LLY, $SLN, $NAMS, $INCY/Escient, Dr. Oz at CMS x.com/biotechch/st... #BioSky $XBI
x.com
x.com
November 22, 2024 at 6:42 PM
On #BiotechHangout, Mike Yee, Bruce Booth, Eric Schmidt & Yaron Werber discuss Jefferies Conference, Atlas Year in Review, investor sentiment, #ACR24 recap $AMGN Ph3 & cell therapy data for SLE, SSC, IMNM & lipid ROs: $LLY, $SLN, $NAMS, $INCY/Escient, Dr. Oz at CMS x.com/biotechch/st... #BioSky $XBI
Phase III trial evaluated subcutaneous abatacept + standard of care (SOC) for idiopathic inflammatory myopathy
Over 24 wks, abatacept+SOC failed to show improved efficacy over placebo; however, patients with non-DM subtypes appeared to have sustained benefit up to 1 year
A&R
acr.tw/3ARxyMs
#Medsky
Over 24 wks, abatacept+SOC failed to show improved efficacy over placebo; however, patients with non-DM subtypes appeared to have sustained benefit up to 1 year
A&R
acr.tw/3ARxyMs
#Medsky
December 3, 2024 at 1:34 PM
Phase III trial evaluated subcutaneous abatacept + standard of care (SOC) for idiopathic inflammatory myopathy
Over 24 wks, abatacept+SOC failed to show improved efficacy over placebo; however, patients with non-DM subtypes appeared to have sustained benefit up to 1 year
A&R
acr.tw/3ARxyMs
#Medsky
Over 24 wks, abatacept+SOC failed to show improved efficacy over placebo; however, patients with non-DM subtypes appeared to have sustained benefit up to 1 year
A&R
acr.tw/3ARxyMs
#Medsky
Wow, this is big. For years, severe autoimmune myositis like IMNM had no approved treatments. Now, a new injection showed a 15.4-point improvement in symptoms for 264 patients in a Phase 3 trial. Real hope for those struggling.
Argenx's VYVGART Hytrulo Shows Positive Phase 3 Results for Autoimmune Myositis
Argenx has announced successful Phase 3 trial results for its drug VYVGART Hytrulo, an under-the-skin injection for autoimmune myositis. This treatment significantly improved symptoms in patients with
www.globenewswire.com
August 18, 2026 at 8:03 PM
Wow, this is big. For years, severe autoimmune myositis like IMNM had no approved treatments. Now, a new injection showed a 15.4-point improvement in symptoms for 264 patients in a Phase 3 trial. Real hope for those struggling.
August 13, 2024 at 7:10 PM
hr-Bigband, “Off the Cuff”
youtu.be/iMnm-9RyXJU
youtu.be/iMnm-9RyXJU
Jim McNeely: "OFF THE CUFF" | Frankfurt Radio Big Band | Goodbye Tony Lakatos!
YouTube video by hr-Bigband – Frankfurt Radio Big Band
youtu.be
July 12, 2025 at 5:56 AM
hr-Bigband, “Off the Cuff”
youtu.be/iMnm-9RyXJU
youtu.be/iMnm-9RyXJU
Figure 2 from a new Review Article shows the spectrum of extramuscular involvement in the four main groups of idiopathic inflammatory myopathy. Learn more about inflammatory myopathies: https://nej.md/49Iy9Oo
#Neurology #Rheumatology
#Neurology #Rheumatology
May 20, 2026 at 1:00 PM
Figure 2 from a new Review Article shows the spectrum of extramuscular involvement in the four main groups of idiopathic inflammatory myopathy. Learn more about inflammatory myopathies: https://nej.md/49Iy9Oo
#Neurology #Rheumatology
#Neurology #Rheumatology
This efgartigimod Ph3 data for autoimmune myositis is a big deal. For immune-mediated necrotizing myopathy (IMNM), a severe muscle-attacking disease with no approved options, patients saw a statistically significant 15.4-point greater improvement in a key symptom score.
argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune M
A global immunology company, argenx, reported positive results from its Phase 3 ALKIVIA study, showing that the drug VYVGART® Hytrulo (efgartigimod) significantly improved symptoms in adults with auto
argenx.com
August 19, 2026 at 2:01 PM
This efgartigimod Ph3 data for autoimmune myositis is a big deal. For immune-mediated necrotizing myopathy (IMNM), a severe muscle-attacking disease with no approved options, patients saw a statistically significant 15.4-point greater improvement in a key symptom score.
#IMNM Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference
https://www.stocktitan.net/news/IMNM/immunome-to-present-at-the-piper-sandler-36th-annual-healthcare-jkxnxvon8b98.html
https://www.stocktitan.net/news/IMNM/immunome-to-present-at-the-piper-sandler-36th-annual-healthcare-jkxnxvon8b98.html
November 27, 2024 at 1:00 PM
#IMNM Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference
https://www.stocktitan.net/news/IMNM/immunome-to-present-at-the-piper-sandler-36th-annual-healthcare-jkxnxvon8b98.html
https://www.stocktitan.net/news/IMNM/immunome-to-present-at-the-piper-sandler-36th-annual-healthcare-jkxnxvon8b98.html
So, you want to use C++ Modules ...cross platform - Daniela Engert - Meeting C++ 2023
www.youtube.com/watch?v=iMNM...
#cpp
#cplusplus
www.youtube.com/watch?v=iMNM...
#cpp
#cplusplus
So, you want to use C++ Modules ...cross platform - Daniela Engert - Meeting C++ 2023
YouTube video by Meeting Cpp
www.youtube.com
March 8, 2025 at 7:47 PM
So, you want to use C++ Modules ...cross platform - Daniela Engert - Meeting C++ 2023
www.youtube.com/watch?v=iMNM...
#cpp
#cplusplus
www.youtube.com/watch?v=iMNM...
#cpp
#cplusplus
Immune-mediated necrotizing myopathy (IMNM) is a rare autoimmune muscle disease marked by severe, symmetric weakness of the proximal muscles and significant muscle fiber necrosis.
Learn more: myositis.org
You may be rare, but you're not alone!
#rareDisease #rareDiseaseAwareness
Learn more: myositis.org
You may be rare, but you're not alone!
#rareDisease #rareDiseaseAwareness
December 16, 2025 at 3:01 PM
Immune-mediated necrotizing myopathy (IMNM) is a rare autoimmune muscle disease marked by severe, symmetric weakness of the proximal muscles and significant muscle fiber necrosis.
Learn more: myositis.org
You may be rare, but you're not alone!
#rareDisease #rareDiseaseAwareness
Learn more: myositis.org
You may be rare, but you're not alone!
#rareDisease #rareDiseaseAwareness
$IMNM +1.85% [Craig-Hallum initiated coverage of Immunome with a Buy rating and a $26 price target.]
September 5, 2025 at 12:09 PM
$IMNM +1.85% [Craig-Hallum initiated coverage of Immunome with a Buy rating and a $26 price target.]
2/3 Nilesh KUMAR, Wellington Management: Avere Therapeutics, KRSA, MBX
Evan McCULLOCH, Franklin Templeton (FBDIX): BBIO, ONC, RVMD
Salveen RICHTER, Goldman Sachs: AMGN, BIIB, IMNM, TSHA, VRTX
Davis RISINGER, Leering Partners: LTGO, ORKA, PCVX, SCTX, TRAX...
Evan McCULLOCH, Franklin Templeton (FBDIX): BBIO, ONC, RVMD
Salveen RICHTER, Goldman Sachs: AMGN, BIIB, IMNM, TSHA, VRTX
Davis RISINGER, Leering Partners: LTGO, ORKA, PCVX, SCTX, TRAX...
September 25, 2026 at 8:45 PM
2/3 Nilesh KUMAR, Wellington Management: Avere Therapeutics, KRSA, MBX
Evan McCULLOCH, Franklin Templeton (FBDIX): BBIO, ONC, RVMD
Salveen RICHTER, Goldman Sachs: AMGN, BIIB, IMNM, TSHA, VRTX
Davis RISINGER, Leering Partners: LTGO, ORKA, PCVX, SCTX, TRAX...
Evan McCULLOCH, Franklin Templeton (FBDIX): BBIO, ONC, RVMD
Salveen RICHTER, Goldman Sachs: AMGN, BIIB, IMNM, TSHA, VRTX
Davis RISINGER, Leering Partners: LTGO, ORKA, PCVX, SCTX, TRAX...
Breaking News: ( NASDAQ: #IMNM ) Immunome Appoints Roee Shahar as Executive Vice President, Commercial
#StockMarket #News
#StockMarket #News
October 8, 2024 at 5:45 PM
Breaking News: ( NASDAQ: #IMNM ) Immunome Appoints Roee Shahar as Executive Vice President, Commercial
#StockMarket #News
#StockMarket #News
Just In: ( NASDAQ: #IMNM ) Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference
#StockMarket #News
#StockMarket #News
November 27, 2024 at 3:55 PM
Just In: ( NASDAQ: #IMNM ) Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference
#StockMarket #News
#StockMarket #News
Pinging Andreas Weis (@comicsansms.bsky.social), he gave the getting started with modules talk last year. And also take a look at what fmt is doing, Daniela Engert has contributed to that www.youtube.com/watch?v=iMNM...
(edit repost)
(edit repost)
C++ Modules - Getting started today - Andreas Weis - Meeting C++ 2024
YouTube video by Meeting Cpp
www.youtube.com
March 13, 2025 at 4:07 PM
Pinging Andreas Weis (@comicsansms.bsky.social), he gave the getting started with modules talk last year. And also take a look at what fmt is doing, Daniela Engert has contributed to that www.youtube.com/watch?v=iMNM...
(edit repost)
(edit repost)
JUST IN: ( NASDAQ: #IMNM ) Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
#StockMarket #News
#StockMarket #News
October 8, 2024 at 5:40 PM
JUST IN: ( NASDAQ: #IMNM ) Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
#StockMarket #News
#StockMarket #News